Stay updated with breaking news from Bioventus inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Canaccord Genuity Group upgraded shares of Bioventus (NYSE:BVS – Free Report) from a hold rating to a buy rating in a research note issued to investors on Thursday, Benzinga reports. The firm currently has $7.00 price objective on the stock, up from their prior price objective of $3.66. A number of other equities research analysts […] ....
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis orthospinenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orthospinenews.com Daily Mail and Mail on Sunday newspapers.
Canaccord Genuity has upgraded Biomedical Devices and Services company Bioventus Inc (NASDAQ: BVS), highlighting greater insight into the progress of the turnaround and plans for future investment and growth. ....
Canaccord Genuity has upgraded Biomedical Devices and Services company Bioventus Inc BVS, highlighting greater insight into the progress of the turnaround and… ....